Translational studies of nicotinic receptor genes: alcohol and nicotine behaviors
烟碱受体基因的转化研究:酒精和尼古丁行为
基本信息
- 批准号:8468086
- 负责人:
- 金额:$ 37.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-01 至 2016-05-31
- 项目状态:已结题
- 来源:
- 关键词:AgeAgonistAlcohol dependenceAlcohol or Other Drugs useAlcoholsAllelesAwardBehaviorBehavioralBehavioral ModelBindingBiological AssayBiological ModelsBiological ProcessCationsCell Culture TechniquesComorbidityComplexDNADNA ResequencingDataDependenceDevelopmentDiseaseDopamineDrosophila acetylcholine receptor alpha-subunitDrug AddictionDrug effect disorderElectrophysiology (science)FamilyFutureGated Ion ChannelGene ExpressionGenesGeneticGenetic RiskGenomicsGenotypeGoalsHeritabilityHumanHuman GeneticsIndividualIntercistronic RegionKnowledgeLaboratoriesLeadLigandsMalignant neoplasm of lungMediatingMentorsMethodsMolecularMusNeuronsNicotineNicotine DependenceNicotinic ReceptorsNucleic Acid Regulatory SequencesPathway interactionsPharmacogenomicsPhenotypePlayPreventionPrevention approachPromoter RegionsPropertyRattusReceptor GeneResearchRewardsRodent ModelRoleSamplingSeveritiesSingle Nucleotide PolymorphismSiteSmokingStudy modelsTestingTobaccoTobacco DependenceTobacco useTrainingUntranslated RegionsVariantWorkXenopus oocyteaddictionalcohol responsealcohol use initiationanti socialbasecareercase controldopaminergic neuronfollow-upgenetic associationgenome wide association studyimprovedmesolimbic systemnovelproblem drinkerpublic health relevancereceptorreceptor functionresponsetranslational study
项目摘要
DESCRIPTION (provided by applicant): Alcohol and nicotine dependence commonly co-occur and a variety of research suggests some of this co-morbidity may be due to overlapping genetic factors. Converging evidence from electrophysiology studies and rodent models of alcohol- and tobacco-related phenotypes supports the hypothesis that neuronal nicotinic receptors (nAChRs) may be a common site of action for these drugs. The nAChRs are ligand-gated ion channels containing a central cation pore that act as the primary targets for nicotine and the endogenous agonist acytelcholine. Alcohol appears to play a role in modulating the pharmacological properties of nicotine binding at nAChRs, usually by enhancing receptor function. Furthermore, several nicotinic receptor subtypes are known to be present on dopaminergic neurons and involved in mediating the release of dopamine in response to alcohol and nicotine. Through this mesolimbic dopaminergic pathway, these receptors (including the 13-7 and 22-4 subunits) may contribute to the rewarding properties associated with substance use. Recent work has provided evidence that several of the human nAChR subunit genes are associated with alcohol and nicotine behaviors in humans, including age of initiation, early subjective response, and dependence. This proposal will extend these human studies in three ways. First, the human genes for the 13-6 and 22-4 nAChR subunits will be resequenced using DNA samples from 100 individuals to identify novel variations. Second, multiple variations in these genes will be characterized in a sample of 4,146 individuals, for which DNA and alcohol and nicotine behavioral data have already been collected, to test for associations between specific DNA variations and these behaviors. Third, laboratory-based methods will be conducted to determine whether specific variations lead differences in gene expression using cell culture assays.
描述(由申请人提供):酒精和尼古丁依赖通常共同发生,各种研究表明,这种共同发病可能是由于重叠的遗传因素。汇聚的证据,从电生理学研究和啮齿动物模型的酒精和烟草相关的表型支持的假设,神经元烟碱受体(nAChRs)可能是一个共同的网站,这些药物的作用。nAChR是含有中央阳离子孔的配体门控离子通道,其充当尼古丁和内源性激动剂乙酰胆碱的主要靶标。酒精似乎在调节尼古丁与nAChR结合的药理学特性中发挥作用,通常是通过增强受体功能。此外,已知几种烟碱受体亚型存在于多巴胺能神经元上,并参与介导响应于酒精和尼古丁的多巴胺释放。通过这种中脑边缘多巴胺能通路,这些受体(包括13-7和22-4亚基)可能有助于与物质使用相关的奖励特性。最近的工作提供了证据表明,几个人类nAChR亚基基因与人类的酒精和尼古丁行为有关,包括开始的年龄,早期主观反应和依赖性。这项提案将从三个方面扩展这些人类研究。首先,将使用来自100名个体的DNA样本对13-6和22-4 nAChR亚基的人类基因进行重新测序,以识别新的变异。第二,这些基因的多种变异将在4,146个个体的样本中进行表征,这些个体的DNA和酒精和尼古丁行为数据已经收集,以测试特定DNA变异与这些行为之间的关联。第三,将进行基于实验室的方法,以确定特定的变异是否导致基因表达的差异,使用细胞培养试验。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARISSA A EHRINGER其他文献
MARISSA A EHRINGER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARISSA A EHRINGER', 18)}}的其他基金
Role of glial expression in nicotine behaviors for genes identified through human GWAS
通过人类 GWAS 鉴定的基因神经胶质表达在尼古丁行为中的作用
- 批准号:
10542587 - 财政年份:2022
- 资助金额:
$ 37.47万 - 项目类别:
Role of glial expression in nicotine behaviors for genes identified through human GWAS
通过人类 GWAS 鉴定的基因神经胶质表达在尼古丁行为中的作用
- 批准号:
10701070 - 财政年份:2022
- 资助金额:
$ 37.47万 - 项目类别:
Translational studies of nicotinic receptor genes: alcohol and nicotine behaviors
烟碱受体基因的转化研究:酒精和尼古丁行为
- 批准号:
7662588 - 财政年份:2009
- 资助金额:
$ 37.47万 - 项目类别:
Translational studies of nicotinic receptor genes: alcohol and nicotine behaviors
烟碱受体基因的转化研究:酒精和尼古丁行为
- 批准号:
7921055 - 财政年份:2009
- 资助金额:
$ 37.47万 - 项目类别:
Nicotinic receptor genes & substance abuse: Functional studies of associated SNPs
烟碱受体基因
- 批准号:
7701421 - 财政年份:2009
- 资助金额:
$ 37.47万 - 项目类别:
Translational studies of nicotinic receptor genes: alcohol and nicotine behaviors
烟碱受体基因的转化研究:酒精和尼古丁行为
- 批准号:
8286349 - 财政年份:2009
- 资助金额:
$ 37.47万 - 项目类别:
Translational studies of nicotinic receptor genes: alcohol and nicotine behaviors
烟碱受体基因的转化研究:酒精和尼古丁行为
- 批准号:
8079083 - 财政年份:2009
- 资助金额:
$ 37.47万 - 项目类别:
Molecular Genetics and Behavior: Alcohol and Tobacco Use
分子遗传学和行为:酒精和烟草的使用
- 批准号:
7682250 - 财政年份:2005
- 资助金额:
$ 37.47万 - 项目类别:
Molecular Genetics and Behavior: Alcohol and Tobacco Use
分子遗传学和行为:酒精和烟草的使用
- 批准号:
7277848 - 财政年份:2005
- 资助金额:
$ 37.47万 - 项目类别:
Molecular Genetics and Behavior: Alcohol and Tobacco Use
分子遗传学和行为:酒精和烟草的使用
- 批准号:
7490510 - 财政年份:2005
- 资助金额:
$ 37.47万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 37.47万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 37.47万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 37.47万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 37.47万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 37.47万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 37.47万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 37.47万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 37.47万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 37.47万 - 项目类别:
Fentanyl Addiction: Individual Differences, Neural Circuitry, and Treatment with a GLP-1 Receptor Agonist
芬太尼成瘾:个体差异、神经回路和 GLP-1 受体激动剂治疗
- 批准号:
10534864 - 财政年份:2023
- 资助金额:
$ 37.47万 - 项目类别:














{{item.name}}会员




